Bausch + Lomb Share Price Today
(NASDAQ: BLCO)

Name: Bausch + Lomb Share Price Today (NASDAQ: BLCO) - Bausch + Lomb Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Bausch + Lomb share price is $17.35 & ₹1,503.20 as on 1 Feb 2025, 2.30 'hrs' IST

$17.35

▲

-0.3

(-1.7%)

Market is closed - opens 8 PM, 03 Feb 2025

View live Bausch + Lomb share price in Dollar and Rupees. Guide to invest in Bausch + Lomb stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Bausch + Lomb, along with analyst recommendations, forecasts, and comprehensive financials.

Bausch + Lomb share price movements

Today's Low: $17.23
Today's High: $17.72
$17.35
0.69%
Downside
Day's Volatility :2.77%
Upside
2.09%
52 Weeks Low: $13.16
52 Weeks High: $21.69
$17.35
24.15%
Downside
52 Weeks Volatility :39.33%
Upside
20.01%

Bausch + Lomb (BLCO) Returns

Period	Bausch + Lomb Corp.	Sector (Health Care)	Index (Russel 2000)
3 Months	-12.68%	-0.6%	0.0%
6 Months	12.66%	-2.8%	0.0%
1 Year	26.83%	3.3%	0.0%
3 Years	-13.25%	11.6%	-13.7%

Bausch + Lomb (BLCO) Key Statistics

in dollars & INR

Previous Close	$17.65
Open	$17.71
Today's High	$17.72
Today's Low	$17.23
Market Capitalization	$6.3B
Today's Volume	$361.0K
52 Week High	$21.69
52 Week Low	$13.16
Revenue TTM	$4.7B
EBITDA	$635.0M
Earnings Per Share (EPS)	$-1.04
Profit Margin	-7.86%
Quarterly Earnings Growth YOY	-0.89%
Return On Equity TTM	-5.23%

How to invest in Bausch + Lomb Stock (BLCO) from India?

It is very easy for Indian residents to invest directly in Bausch + Lomb from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Bausch + Lomb stock in both Indian Rupees (INR) and US Dollars (USD). Search for Bausch + Lomb or BLCO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Bausch + Lomb or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Bausch + Lomb shares which would translate to 0.050 fractional shares of Bausch + Lomb as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Bausch + Lomb, in just a few clicks!

Returns in Bausch + Lomb (BLCO) for Indian investors in Rupees

The Bausch + Lomb stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Bausch + Lomb investment value today

Current value as on today

₹1,31,387

Returns

₹31,387

(+31.39%)

Returns from Bausch + Lomb Stock

₹26,827 (+26.83%)

Dollar Returns

₹4,559 (+4.56%)

Indian investors sentiment towards Bausch + Lomb (BLCO)

-32%

Period: Jan 2, 2025 to Feb 1, 2025. Change in 30 Days versus previous period

Search interest for Bausch + Lomb Stock from India on INDmoney has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Bausch + Lomb

Maple Rock Capital Partners, Inc.
1.03%
ICAHN CARL C
0.99%
Goldentree Asset Management LP
0.95%
Alberta Investment Management Corp
0.63%
River Road Asset Management, LLC
0.57%
D. E. Shaw & Co LP
0.54%

Analyst Recommendation on Bausch + Lomb

Buy

55%Buy

44%Hold

0%Sell

Based on 18 Wall street analysts offering stock ratings for Bausch + Lomb(by analysts ranked 0 to 5 stars)

Based on 18 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Bausch + Lomb Stock (BLCO)

What analysts predicted

Upside of 19.1%

Target:

$20.66

Current:

$17.35

Insights on Bausch + Lomb Stock (Ticker Symbol: BLCO)

Price Movement
In the last 1 month, BLCO stock has moved down by -3.9%
Decreasing Revenue
Revenue is down for the last 2 quarters, 1.21B → 1.19B (in $), with an average decrease of 1.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -167.0M → -124.0M (in $), with an average increase of 16.2% per quarter
BLCO vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 49.0% return, outperforming this stock by 25.9%
Price to Sales
ForBLCO every $1 of sales, investors are willing to pay $1.3, whereas for Intuitive Surgical, Inc., the investors are paying $25.7 for every $1 of sales.

BLCO Bausch + Lomb Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$3.7B	-
Net Income	$710.0M	-
Net Profit Margin	19.37%	-

	FY19	Y/Y Change
Revenue	$3.8B	↑ 3.08%
Net Income	$298.0M	↓ 58.03%
Net Profit Margin	7.89%	↓ 11.48%

	FY20	Y/Y Change
Revenue	$3.4B	↓ 9.69%
Net Income	$-17.0M	↓ 105.7%
Net Profit Margin	-0.5%	↓ 8.39%

	FY21	Y/Y Change
Revenue	$3.8B	↑ 10.35%
Net Income	$182.0M	↓ 1170.59%
Net Profit Margin	4.83%	↑ 5.33%

	FY22	Y/Y Change
Revenue	$3.8B	↑ 0.08%
Net Income	$15.0M	↓ 91.76%
Net Profit Margin	0.4%	↓ 4.43%

	FY23	Y/Y Change
Revenue	$4.1B	↑ 10.03%
Net Income	$-260.0M	↓ 1833.33%
Net Profit Margin	-6.27%	↓ 6.67%

	Q2 FY23	Q/Q Change
Revenue	$1.0B	↑ 11.17%
Net Income	$-32.0M	↓ 63.64%
Net Profit Margin	-3.09%	↑ 6.36%

	Q3 FY23	Q/Q Change
Revenue	$1.0B	↓ 2.71%
Net Income	$-84.0M	↑ 162.5%
Net Profit Margin	-8.34%	↓ 5.25%

	Q4 FY23	Q/Q Change
Revenue	$1.2B	↑ 16.48%
Net Income	$-54.0M	↓ 35.71%
Net Profit Margin	-4.6%	↑ 3.74%

	Q1 FY24	Q/Q Change
Revenue	$1.1B	↓ 6.31%
Net Income	$-167.0M	↑ 209.26%
Net Profit Margin	-15.2%	↓ 10.6%

	Q2 FY24	Q/Q Change
Revenue	$1.2B	↑ 10.65%
Net Income	$-151.0M	↓ 9.58%
Net Profit Margin	-12.42%	↑ 2.78%

	Q3 FY24	Q/Q Change
Revenue	$1.2B	↓ 1.64%
Net Income	$-124.0M	↓ 17.88%
Net Profit Margin	-10.37%	↑ 2.05%

	FY18	Y/Y Change
Profit	$2.4B	-

	FY19	Y/Y Change
Profit	$2.5B	↑ 4.21%

	FY20	Y/Y Change
Profit	$2.1B	↓ 13.22%

	FY21	Y/Y Change
Profit	$2.3B	↑ 8.04%

	FY22	Y/Y Change
Profit	$2.2B	↓ 2.13%

	FY23	Y/Y Change
Profit	$2.5B	↑ 11.34%

	Q2 FY23	Q/Q Change
Profit	$618.0M	↑ 10.55%

	Q3 FY23	Q/Q Change
Profit	$615.0M	↓ 0.49%

	Q4 FY23	Q/Q Change
Profit	$712.0M	↑ 15.77%

	Q1 FY24	Q/Q Change
Profit	$601.0M	↓ 15.59%

	Q2 FY24	Q/Q Change
Profit	$659.0M	↑ 9.65%

	Q3 FY24	Q/Q Change
Profit	$660.0M	↑ 0.15%

	FY18	Y/Y Change
Operating Cash Flow	$763.0M	-
Investing Cash Flow	$-74.0M	-
Financing Cash Flow	$-665.0M	-

	FY19	Y/Y Change
Operating Cash Flow	$799.0M	↑ 4.72%
Investing Cash Flow	$-186.0M	↑ 151.35%
Financing Cash Flow	$-606.0M	↓ 8.87%

	FY20	Y/Y Change
Operating Cash Flow	$522.0M	↓ 34.67%
Investing Cash Flow	$-256.0M	↑ 37.63%
Financing Cash Flow	$-232.0M	↓ 61.72%

	FY21	Y/Y Change
Operating Cash Flow	$873.0M	↑ 67.24%
Investing Cash Flow	$-214.0M	↓ 16.41%
Financing Cash Flow	$-712.0M	↑ 206.9%

	FY22	Y/Y Change
Operating Cash Flow	$345.0M	↓ 60.48%
Investing Cash Flow	$-215.0M	↑ 0.47%
Financing Cash Flow	$81.0M	↓ 111.38%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-24.0M	↓ 57.14%
Investing Cash Flow	$-28.0M	↓ 56.25%
Financing Cash Flow	$90.0M	↓ 1.1%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$48.0M	↓ 300.0%
Investing Cash Flow	$-1.9B	↑ 6621.43%
Financing Cash Flow	$1.8B	↑ 1912.22%

Bausch + Lomb Technicals Summary

Sell

Neutral

Buy

Bausch + Lomb is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Bausch + Lomb (BLCO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Bausch + Lomb Corp.	-2.2%	12.66%	26.83%	-13.25%	-13.25%
Intuitive Surgical, Inc.	9.13%	30.57%	48.95%	100.24%	198.86%
Alcon Ag	9.16%	1.65%	20.81%	18.34%	50.41%
West Pharmaceutical Services Inc	4.01%	13.25%	-14.1%	-15.07%	114.89%
Resmed Inc.	3.37%	9.5%	24.23%	-0.35%	41.55%
Becton, Dickinson And Company	9.32%	5.01%	5.33%	-8.49%	-12.95%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Bausch + Lomb Corp.	914.0	NA	0.7	0.59	-0.05	0.01	NA	18.72
Intuitive Surgical, Inc.	89.35	89.35	4.04	8.05	0.16	0.08	NA	43.75
Alcon Ag	39.45	39.45	3.33	3.03	0.06	0.03	0.0	43.25
West Pharmaceutical Services Inc	51.03	51.03	6.34	6.63	0.18	0.1	0.0	37.96
Resmed Inc.	30.38	30.38	1.92	9.33	0.24	0.13	0.01	35.39
Becton, Dickinson And Company	42.25	42.25	1.13	14.35	0.06	0.03	0.02	89.47

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Bausch + Lomb Corp.	Buy	$6.3B	-13.25%	914.0	-7.86%
Intuitive Surgical, Inc.	Buy	$204.0B	198.86%	89.35	28.51%
Alcon Ag	Buy	$45.9B	50.41%	39.45	11.89%
West Pharmaceutical Services Inc	Buy	$24.9B	114.89%	51.03	17.37%
Resmed Inc.	Buy	$37.8B	41.55%	30.38	23.15%
Becton, Dickinson And Company	Buy	$71.8B	-12.95%	42.25	7.13%

About Bausch + Lomb

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. The company has collaboration agreement with City Therapeutics, Inc. to develop a Novel RNAi-Based treatment for geographic atrophy. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Organization	Bausch + Lomb
Employees	13000
CEO	Mr. Brenton L. Saunders J.D.
Industry	Healthcare

Management People of Bausch + Lomb

Name	Title
Mr. Brenton L. Saunders J.D.	CEO & Chairman
Mr. Osama A. Eldessouky	Executive VP & CFO
Mr. A. Robert D. Bailey	Executive VP & Chief Legal Officer
Dr. Yehia Hashad M.D.	Executive VP of Research & Development and Chief Medical officer
Mr. Andrew Stewart	President of Global Pharmaceuticals & International Consumer
Mr. Alan Waterhouse CPFA, MBA	Executive VP and Chief Supply Chain & Operations Officer
Mr. Frederick J. Munsch	Senior VP, Controller & Chief Accounting Officer
Mr. Jonathon L. Kellerman	Chief Compliance Officer
Mr. T.J. Crawford	Chief Communications Officer
Dr. Manisha A. Narasimhan Ph.D.	Chief Corporate Development & Digital Officer

Important FAQs about investing in BLCO Stock from India :

What is Bausch + Lomb share price today?

Bausch + Lomb share price today stands at $17.35, Open: $17.71 ; Previous Close: $17.65 ; High: $17.72 ; Low: $17.23 ; 52 Week High: $21.69 ; 52 Week Low: $13.16.

The stock opens at $17.71, after a previous close of $17.65. The stock reached a daily high of $17.72 and a low of $17.23, with a 52-week high of $21.69 and a 52-week low of $13.16.

Can Indians buy Bausch + Lomb shares?

Yes, Indians can invest in the Bausch + Lomb (BLCO) from India.

With INDmoney, you can buy Bausch + Lomb at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Bausch + Lomb at zero transaction cost.

How can I buy Bausch + Lomb shares from India?

It is very easy to buy Bausch + Lomb from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Bausch + Lomb (BLCO) be purchased?

Yes, you can buy fractional shares of Bausch + Lomb with INDmoney app.

What are the documents required to start investing in Bausch + Lomb stocks?

To start investing in Bausch + Lomb, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.